Lv4
660 积分 2022-11-21 加入
Atypical chemokine receptors in the immune system
3天前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
12天前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
12天前
已完结
Early and long-term efficacy and safety of remibrutinib in patients with chronic spontaneous urticaria: 52-week data from the Phase 3 REMIX-1 and REMIX-2 studies
12天前
已完结
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
12天前
已完结
Trends in the drug target landscape for autoimmune diseases
14天前
已完结
Trends in the drug target landscape for autoimmune diseases
25天前
已完结
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
25天前
已完结
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma
2个月前
已完结
Molecular Patterns in Acute Pancreatitis Reflect Generalizable Endotypes of the Host Response to Systemic Injury in Humans
4个月前
已完结
皖公网安备34019202002308
